The company's vaccine has shown to be 85% effective against severe forms of the disease. Patients will only need to receive one shot instead of two, as with other vaccines already in use in the U.S.
Copyright 2021 NPR
© 2025
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations